| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.32B | 2.20B | 2.09B | 1.84B | 1.59B |
| Gross Profit | 1.22B | 1.19B | 1.11B | 972.79M | 805.04M |
| EBITDA | 965.96M | 872.88M | 788.00M | 610.36M | 581.08M |
| Net Income | 597.04M | 537.13M | 468.17M | 396.92M | 399.59M |
Balance Sheet | |||||
| Total Assets | 4.30B | 4.06B | 3.96B | 4.01B | 2.22B |
| Cash, Cash Equivalents and Short-Term Investments | 355.10M | 492.60M | 457.65M | 536.49M | 717.85M |
| Total Debt | 1.56B | 1.57B | 1.84B | 2.22B | 866.25M |
| Total Liabilities | 2.12B | 2.14B | 2.34B | 2.68B | 1.21B |
| Stockholders Equity | 2.19B | 1.91B | 1.62B | 1.33B | 1.02B |
Cash Flow | |||||
| Free Cash Flow | 617.45M | 614.66M | 584.79M | 487.12M | 493.90M |
| Operating Cash Flow | 726.26M | 700.34M | 645.57M | 538.28M | 555.23M |
| Investing Cash Flow | -392.77M | -144.32M | -95.39M | -2.03B | -135.99M |
| Financing Cash Flow | -407.82M | -560.85M | -632.02M | 1.34B | -322.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $10.71B | 18.36 | 28.83% | 1.49% | 5.88% | 12.18% | |
78 Outperform | $96.14B | 43.33 | 57.08% | 0.73% | 8.77% | 13.62% | |
73 Outperform | $165.43B | 39.72 | 12.57% | 0.73% | 9.04% | 21.35% | |
73 Outperform | $349.87M | 16.50 | 21.02% | 3.31% | -3.75% | -4.34% | |
71 Outperform | $8.80B | 24.33 | 24.42% | 0.84% | 7.76% | 15.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | $45.28B | 38.20 | ― | 1.24% | 9.02% | 3.45% |
At its 2025 Annual Meeting of Stockholders held on December 18, 2025, FactSet Research Systems received stockholder approval for a series of governance and compensation measures, including the 2025 Omnibus Incentive Plan and a new Employee Stock Purchase Plan, alongside advisory approval of fiscal 2025 executive pay and the re‑election of all ten director nominees for one‑year terms. Stockholders also ratified Ernst & Young LLP as the independent auditor for the fiscal year ending August 31, 2026, and approved amendments to the company’s certificate of incorporation that reduce the voting threshold for stockholder action by written consent from a supermajority to a simple majority and remove obsolete language on board declassification, with the Third Amended and Restated Certificate of Incorporation becoming effective upon filing in Delaware on December 22, 2025, collectively reinforcing FactSet’s equity‑based compensation framework and signaling a shift toward more shareholder‑friendly governance.
The most recent analyst rating on (FDS) stock is a Hold with a $305.00 price target. To see the full list of analyst forecasts on Factset Research stock, see the FDS Stock Forecast page.